News - Sunshine Labs

03/07/2023

‍The crisis of overdose deaths in British Columbia is a multifaceted and complex issue. British Columbia has taken a pioneering role in addressing this crisis by establishing the first supervised injection sites in North America, implementing widespread access to opiate replacement therapy, making novel treatment options available through physicians, and decriminalizing the possession of small … Continued

News

07/08/2025

DMT in Medical Research

Dimethyltryptamine (DMT) is a naturally occurring psychedelic compound that has gained significant attention in recent years for its potential therapeutic applications. Once known primarily for its role in traditional Amazonian medicine and its powerful hallucinogenic effects, DMT is now being rigorously studied in clinical settings for its impact on mental health. What Is DMT? DMT … Continued

Press

06/30/2025

Sunshine Labs and Speranza Therapeutics Forge a Global Partnership

Expanding Access to Life-Saving Harm Reduction Solutions BOCA RATON, Fla. and TORONTO, June 25, 2025 Sunshine Labs is proud to announce a strategic global partnership with Speranza Therapeutics, a leader in medical device innovation and addiction medicine. This collaboration marks a major milestone in our mission to expand access to clinically effective harm reduction tools, pharmaceuticals, and medical devices … Continued

News

04/15/2025

Global Distribution Secured for Neurostimulation Detox Device

April 15, 2025 — Sunshine Labs, a leading innovator in medical technologies for Substance Use Disorder (SUD), is pleased to announce an exclusive global distribution agreement (excluding the United States) with Sperenza Therapeutics for its flagship device, S.T. Genesis™, with its wholly owned subsidiary, Waxed International. This agreement with Speranza Therapeutics grants Waxed International exclusive … Continued

News

05/07/2025

Transforming the Drug Crisis Response

Current Research on Evidence-Based Solutions As Canada and the rest of the world continue to grapple with a massive public health crisis driven by toxic, unregulated drugs, a growing body of new evidence is reshaping the response. Prescribed alternatives-commonly known as “safer supply”– are an effective, evidence-based strategy to reduce overdose deaths and improve the … Continued

News

03/11/2025

Announcing Our First Import License

Advancing Pharmaceutical Innovation with Compliance and Safety We are thrilled to announce a major milestone in our journey: the approval of our first import license for a highly specialized raw material. This marks a significant step forward in our mission to support the pharmaceutical industry with safe, compliant, and high-quality products. About The Product The … Continued

Press

01/22/2025

A Potential New Approach to Treating Addiction

GLP-1 (Glucagon-like peptide-1 receptor agonists), originally developed for type 2 diabetes and obesity, are now being explored for their potential to treat substance use disorders (SUD). Early research suggests these medications could help curb addictive behaviors, opening much needed novel treatment approaches for addiction. What is GLP-1? GLP-1 is a hormone that helps regulate blood … Continued

Company

03/06/2024

Diacetylmorphine for Addiction Treatment

The Role of Diacetylmorphine in the Safer Supply Response to the Toxic Drug Crisis The ongoing toxic drug crisis has claimed thousands of lives due to an unpredictable illegal drug supply contaminated with highly potent synthetic opioids like fentanyl. One approach that shows promise in reducing overdoses and other harms is providing a safer supply … Continued

News

03/05/2024

Backlash against drug decriminalization ‘terrifies’ B.C.’s exiting chief coroner

CBC News · Posted: Feb 01, 2024 Lisa Lapointe says significant policy change at all levels of government is needed to save lives. Since she became B.C.’s chief coroner in February 2011, Lisa Lapointe has seen a lot change. In 2016, the province declared a public health emergency over drug poisoning deaths. In 2023, B.C. decriminalized the possession of … Continued

News

01/31/2024

Psychedelic research secures first-ever European Union grant of €6.5 million

Marking a historic first for Europe, the European Union has funded research into psychedelic therapy as part of its Horizon Europe programme. Published on 24th January 2024 By Stephanie Price The EU has awarded €6.5 million to a consortium of 19 partners from nine different European countries for a clinical trial – the PsyPal trial. The … Continued

News

02/07/2024

Sunshine Labs: Sassafras & MDMA

Sassafras: the Root of MDMA Sassafras, a plant native to Eastern North America and Asia, has long been known for its medicinal properties. Among the Kituwah (Aniyvwiya) people of the Southeastern US, it serves as a traditional remedy to treat skin conditions, fevers, and urinary issues. In Traditional Chinese Medicine, Asian varieties of Sassafras are … Continued